Menu
Translate
Text Size Print E-mail

National Cancer Institute

The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), leads the National Cancer Program and is the lead federal agency for cancer research, including research into AIDS-related cancers. Research on cancers related to HIV and AIDS is conducted throughout the NCI, and the NCI’s Center of Cancer Research also conducts HIV/AIDS research on its campuses in Bethesda and Frederick, MD. NCI’s Office of HIV and AIDS Malignancy coordinates the HIV research in the NCI and supports robust and varied research programs in the United States and in many low and middle income countries. NCI’s Office of Communications and Education develops and maintains evidence-based information about AIDS-related cancers.

Content provided by NCI.

Connect with NCI

Featured Resources

  • Read related AIDS.gov blog posts.
  • HIV/AIDS Research at the NCI: A Record of Sustained Excellence - Presents highlights of research conducted at NCI that contributed to the understanding of the disease and how NCI’s investment and sustained commitment to exploration and discovery has led, and continues to lead, new approaches and interventions to improve the lives of patients with cancer and HIV/AIDS.
  • AIDS-Related Cancers - A collection of links to evidence-based information about AIDS-related cancers, including treatment, clinical trials, research and other topics
  • AIDS Malignancy Consortium - The AIDS Malignancy Consortium (AMC) is an NCI-supported clinical trials group founded in 1995 to support innovative trials for HIV-associated cancers. Trials are carried out by eight US sites and 4 international sites.
  • AIDS and Cancer Specimen Resource - Biospecimens are biological materials from people (such as tissue, blood, plasma, and urine) that can be used for diagnosis and basic research.The AIDS Cancer Specimen Resource is a biorepository (collection of stored samples with associated data) for HIV-infected human biospecimens that serves as a resource for investigators working in diverse fields such as HIV/AIDS, cancer, virology, immunology, and pathology.

Last revised: 05/01/2012